Sex Differences in Antiarrhythmic Effects of Empagliflozin: The EMPA-ICD Trial Subanalysis | JACC Asia

About this episode

Dr. Jian'an Wang provides commentary on the sex differences observed in the antiarrhythmic effects of Empagliflozin based on the EMPA-ICD trial subanalysis.

Commentary by Dr. Jian'an Wang.

People in this episode

Guest: Dr. Jian'an Wang

Topics covered

• antiarrhythmic effects
• Empagliflozin
• sex differences
• cardiology
• clinical trials

Keywords

• Empagliflozin
• antiarrhythmic
• sex differences
• EMPA-ICD trial
• cardiology

Mentioned in this episode

Organizations: American College of Cardiology

More episodes of JACC Specialty Journals

• Comparison of Flow Ratio Derived From IVUS With CAG in Complex Lesions: Correlation With FFR | JACC Asia · June 2, 2026 · 1 min
• Sex Differences in Antiarrhythmic Effects of Empagliflozin: The EMPA-ICD Trial Subanalysis | JACC Asia · June 2, 2026 · 1 min
• Association Between Cardiac Acceleration Capacity and Susceptibility to Vasovagal Syncope: Autonomic Dysregulation in Vasovagal Syncope | JACC Asia · June 2, 2026 · 0 min
• Cardio-Kidney-Metabolic Phenotypes and Adverse Clinical Outcomes in Patients With Atrial Fibrillation | JACC Asia · June 2, 2026 · 0 min
• Postoperative New-Onset Heart Block in Noncardiac Surgery: Model Development, Validation, and Long-Term Prognostic Analysis | JACC Asia · June 2, 2026 · 0 min
• The Associations Between Heart Rate, Deformational Echocardiographic Parameters, and Outcomes in Patients With Atrial Fibrillation | JACC Asia · June 2, 2026 · 1 min